Human cytomegalovirus (HCMV) is an important human pathogen that causes severe morbidity and mortality in the immunocompromised and immunosuppressed individual. The virus has the ability to cross the placenta and infect the fetus in utero which can lead to severe congenital abnormalities and birth defects. Human cytomegalovirus (HCMV) gene expression is a complex, coordinated process consisting of three phases, immediate early (IE), early and late. IE proteins regulate viral and cellular gene expression and are important for activation of early promoters. Specifically, IE1 and 2 act synergistically to activate early promoters. Studies have demonstrated that other IE genes (UL36-38, IRS1 and TRS1) as well as at least two early gene products (UL69 and UL112- 113) function to enhance IE1 and 2 mediated activation of early promoters. The early phase of the virus life cycle is necessary to prepare the cell for virus DNA replication. It is generally thought that if the virus proceeds through the early phase and properly initiates virus DNA replication, then the infection will result in the generation of infectious progeny. Therefore, the early phase of virus DNA replication is thought to be a commitment point for the successful completion of infectious progeny production. In this proposal, we will conduct studies to address how vital transacting proteins, and in particular how IE1 and 2, UL112-113 and IRS1/TRS1 proteins regulate viral early promoters. The promoters chosen, pol (UL54), UL44 and ICP8 (UL57) are members of the 11 loci shown to be important for viral DNA replication. We will 1) identify those transacting regulatory proteins which influence early promoter activity, 2) identify domains within those proteins which carry out this effect, 3) identify the sequences within the early promoters responsive to viral proteins which augment IE1 and 2 mediated activation of early promoters and characterize the proteins that interact with those sequences, 4) characterize the interaction of IE proteins with the pol promoter and the basal transcription factor complex and 5) test the biological relevance of the identified promoter elements in the context of the viral genome and to use these recombinant viruses to begin to address cell type specific differences in the regulation of HCMV early promoters.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI023313-12
Application #
2886502
Study Section
Virology Study Section (VR)
Program Officer
Beisel, Christopher E
Project Start
1989-07-01
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
12
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Eastern Virginia Medical School
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
City
Norfolk
State
VA
Country
United States
Zip Code
23501
Ciocco-Schmitt, Gina M; Karabekian, Zaruhi; Godfrey, Earl W et al. (2002) Identification and characterization of novel murine cytomegalovirus M112-113 (e1) gene products. Virology 294:199-208
McWatters, Bernard J P; Stenberg, Richard M; Kerry, Julie A (2002) Characterization of the human cytomegalovirus UL75 (glycoprotein H) late gene promoter. Virology 303:309-16
Kerry, J A; Priddy, M A; Staley, T L et al. (1997) The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection. J Virol 71:2120-6
Ishov, A M; Stenberg, R M; Maul, G G (1997) Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J Cell Biol 138:5-16
Iskenderian, A C; Huang, L; Reilly, A et al. (1996) Four of eleven loci required for transient complementation of human cytomegalovirus DNA replication cooperate to activate expression of replication genes. J Virol 70:383-92
Stenberg, R M (1996) The human cytomegalovirus major immediate-early gene. Intervirology 39:343-9
Kerry, J A; Priddy, M A; Jervey, T Y et al. (1996) Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infection. J Virol 70:373-82
Adam, B L; Jervey, T Y; Kohler, C P et al. (1995) The human cytomegalovirus UL98 gene transcription unit overlaps with the pp28 true late gene (UL99) and encodes a 58-kilodalton early protein. J Virol 69:5304-10
Kerry, J A; Sehgal, A; Barlow, S W et al. (1995) Isolation and characterization of a low-abundance splice variant from the human cytomegalovirus major immediate-early gene region. J Virol 69:3868-72
Stenberg, R M; Kerry, J A (1995) Cytomegalovirus genes: their structure and function. Scand J Infect Dis Suppl 99:3-6

Showing the most recent 10 out of 20 publications